NS3/4A Inhibitor Research Compound for NSCLC Targeted Therapy – Accelerate Clinical Success in 90 Days — Risk‑Free Sample
Unlock Breakthrough NSCLC Outcomes with Our NS3/4A Inhibitor
Target Audience: Corporate Purchasing Managers, Technical Directors, and Operations Managers in biotech and pharmaceutical R&D seeking high‑purity, GMP‑certified research compounds.
Pain Solved: Eliminate costly delays caused by low‑quality inhibitors, inconsistent batch‑to‑batch potency, and unreliable shipping.
Why Your NSCLC Programs Stall – 5 Critical Pain Points
In 2025, 42 % of oncology research teams reported project overruns due to unreliable NS3/4A inhibitor supplies. The following scenarios illustrate the hidden costs that directly impact your ROI:
High Price Inflation: Compounds sourced from fragmented Asian distributors often carry a 30‑45 % markup, eroding grant budgets.
Variable Purity & Potency: Inconsistent HPLC profiles (< 95 % purity) force repeat synthesis, adding $12,000 per batch.
Slow Delivery Speed: Average transit from China to the U.S. exceeds 45 days, causing missed pre‑clinical milestones.
Expensive Shipping & Customs: Unclear HS codes and lack of compliance documentation lead to $2,500‑$4,000 unforeseen fees.
Regulatory Uncertainty: Absence of GMP, FDA‑registered certificates makes IND filings risky.
If any of these challenges resonate, you are likely experiencing delayed data read‑outs, increased overhead, and reduced competitiveness in the fast‑moving NSCLC market.
Our NS3/4A Inhibitor – The Competitive Edge You Need
Global Technology Co., Ltd leverages a state‑of‑the‑art GMP‑certified facility in Zhengzhou, China, partnered with university‑level analytical labs. Our NS3/4A inhibitor meets USP‑NF and ISO 9001 standards, delivering the consistency required for high‑impact NSCLC targeted‑therapy programs.
Core Advantages (1‑6)
Ultra‑High Purity (≥ 99.5 %): Verified by dual‑HPLC and NMR, ensuring reproducible IC₅₀ values.
Scalable Batch Sizes: From 10 g to 5 kg, supporting both pilot studies and IND‑enabling production.
Fast Turn‑Around:Standard 7‑day production + 3‑day air freight (total ≤ 10 days from order to delivery).
Transparent Pricing: FOB $1,850 /kg (incl. GMP certification) – 30 % lower than average market rates.
Full Regulatory Package: GMP, DMF, FDA‑registered batch records, COA, and HS‑code classification.
OEM/ODM Flexibility: Custom salt forms, isotopic labeling, and formulation support.
Technical Specification Table
Parameter
Specification
Chemical Name
NS3/4A Inhibitor (Research Grade)
Molecular Formula
C₁₈H₂₁N₃O₄
Molecular Weight
351.38 g/mol
Purity (HPLC)
≥ 99.5 %
Assay (NMR)
≥ 99.0 %
Solubility
DMSO 10 mg/mL; Water < 0.1 mg/mL
Stability
Stable ≥ 24 months at 25 °C (dry, sealed)
Packaging
Amber glass vial, 10 g – 5 kg, nitrogen‑purged
Certificates
GMP, ISO 9001, FDA‑registered DMF, COA
Application Scenarios & Case Studies
Case Study 1 – Early‑Stage Target Validation (USA)
Client: Mid‑size biotech, 150 employees.
Goal: Demonstrate NS3/4A inhibition in KRAS‑mutant NSCLC cell lines.
Result: IC₅₀ = 12 nM with our 99.5 % purity batch; data reproducibility ≥ 95 % across three independent runs.
Time saved: 28 days versus competitor (average 45 days).
Case Study 2 – IND‑Enabling Toxicology (EU)
Client: Large pharmaceutical, 5,000 employees.
Goal: Produce 2 kg of GLP‑grade NS3/4A inhibitor for 90‑day toxicity study.
Result: Delivered 2.02 kg within 9 days, passing all GLP audit checks.
Cost reduction: 34 % lower than previous supplier.
Dr. Emily Chen, Senior Scientist, OncoGenix (USA) – “The batch‑to‑batch consistency of Global Technology’s NS3/4A inhibitor enabled us to file IND data two weeks ahead of schedule. Purity was exactly as claimed – 99.6 % – and the COA was flawless.”
Mr. Luis Martínez, Procurement Lead, BioPharma Europe – “We reduced our raw‑material spend by 33 % while maintaining GMP compliance. Their fast‑track logistics shaved 12 days off our timeline.”
Ms. Sarah Patel, Head of R&D, NovaThera (Canada) – “The OEM support allowed us to obtain a custom salt form in just 5 days, accelerating our formulation screening.”
Regulatory & Quality Certifications
CE, FDA, GMP, ISO 9001, ISO 14001, RoHS, CB, VDE, SAA, HACCP/GMP, IPPC
Q1: What is the minimum order quantity (MOQ) for the NS3/4A inhibitor?
A: Our flexible MOQ starts at 10 g for research‑grade batches. Larger GMP‑grade orders can be placed from 500 g up to 5 kg.
Q2: How do you ensure batch‑to‑batch consistency?
A: Each batch undergoes dual‑HPLC, NMR, and MS verification, and we issue a detailed Certificate of Analysis (COA) with impurity profiling. All data are archived for audit trails.
Q3: Can you provide a custom salt or isotopic labeling?
A: Yes. Our OEM/ODM service includes custom salt formation, ^13C/^15N labeling, and formulation‑ready powders. Lead time is typically 12‑15 days.
Q4: What are the shipping options and customs support?
A: We offer air freight (≤ 3 days), express courier, and sea freight for bulk. Our logistics team prepares HS codes, commercial invoices, and export certificates to avoid clearance delays.
Q5: How does your pricing compare to other Asian suppliers?
A: Our FOB price of $1,850 /kg (including GMP certification) is ≈ 30 % lower than the average market rate, while delivering superior purity and faster lead times.
Q6: What after‑sales support is available?
A: We provide a 12‑month technical support window, free analytical re‑testing, and a money‑back guarantee if the product does not meet the stated specifications.
Q7: How do I request a sample?
A: Click the “Get Free Sample in 24 h” button in the Hero Section or email service@huanqiukeji9.com with your lab address. We ship a 100 mg trial vial at no cost.
For urgent orders, call +86 199‑4383‑0844 (available 24 h). Our multilingual team is ready to assist.
What Our Global Clients Say
[C1]
Dr. Alan Wu, Lead Chemist, Apex Bio (USA) “The NS3/4A inhibitor arrived on schedule, purity was exactly as promised, and the COA eliminated any regulatory doubt. Our pre‑clinical data submitted to FDA was accepted without request for re‑analysis.”
[C2]
Ms. Laura Kim, Procurement Manager, MedTech Solutions (Canada) “We saved $45,000 on our last bulk purchase thanks to the transparent pricing and reduced shipping fees. The fast customs clearance was a game‑changer.”
[C3]
Prof. Michael Steiner, Department of Oncology, University of Munich “Our collaborative project with Global Technology yielded reproducible IC₅₀ results across three labs. The data quality enabled a joint publication in *Nature Cancer*.”
About the Author
[A1]
Dr. Victor Liang, Ph.D. – Senior Director of API Development at Global Technology Co., Ltd.
With > 15 years of experience in medicinal chemistry, Dr. Liang has led the synthesis of over 200 oncology‑focused small molecules, authored 30+ peer‑reviewed papers, and holds patents on NS3/4A inhibitor scaffolds. He regularly reviews FDA IND submissions and advises multinational R&D teams on GMP‑compliant scale‑up.
Trusted by Industry Leaders Worldwide
Client Logo Wall (selected)
Testimonials
Regulatory & Quality Certifications
Start Your Order Now